Markets.com Logo
markets.com

COVAX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --
  • Previous Close
    --
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

COVAX.US represents Ocugen Inc., a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing therapies to prevent and treat respiratory diseases, including COVID-19. Their COVID-19 vaccine candidate, Covaxin, was co-developed with Bharat Biotech of India and is approved for emergency use in India. Ocugen sought emergency use authorization for Covaxin in the US and Canada, but has faced regulatory hurdles. The company's pipeline also includes gene therapy programs targeting inherited retinal diseases like retinitis pigmentosa and Stargardt disease.
markets.com
Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Julian Parker|--
AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Daniel Carter|--
AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

Julian Parker|--
British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

Julian Parker|--
Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Julian Parker|--

Factors

COVAX.US Price Factors: Global Vaccine Demand: Increased global demand for COVID-19 vaccines, especially in developing nations, tends to elevate the price of COVAX.US due to its mission.

Funding Availability: The level of financial support from governments, philanthropic organizations, and other donors directly impacts COVAX.US's procurement capacity and influence on vaccine prices.

Vaccine Supply and Production: Manufacturing capacity and supply chain efficiency affect vaccine availability, influencing prices, especially if there are shortages.

Distribution and Logistics: Costs associated with transporting, storing, and distributing vaccines globally, particularly in resource-limited settings, impact overall expenses and COVAX.US's financial position.

Geopolitical Factors: International relations, trade agreements, and political instability can disrupt supply chains, affect vaccine pricing, and influence COVAX.US's operations.

People Also Watch

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Julian Parker|--
McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

Julian Parker|--
Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

Julian Parker|--

Latest Education Articles

Risk Management 101

Risk Management 101

Julian Parker|--
Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

Julian Parker|--
Gold Scalping Strategy: How Scalping XAU/USD Works

Gold Scalping Strategy: How Scalping XAU/USD Works

Julian Parker|--
Recommended Topics
markets.com